LRLauren M. Rossen

Lauren M. Rossen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lauren M. Rossen has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Amy M. Branum

    Office of the Center Director, National Center for Health Statistics, CDC, Hyattsville, MD

    8 shared publications
  • Farida B. Ahmad

    National Center for Health Statistics, Hyattsville, MD, USA

    7 shared publications
  • Robert N. Anderson

    Division of Vital Statistics , National Center for Health Statistics, Centers for Disease Control and Prevention , Hyattsville , MD , USA

    5 shared publications
  • Diba Khan

    Division of Research Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland

    4 shared publications
  • Kenneth C. Schoendorf

    From the aInfant, Child, and Women’s Health Statistics Branch, Office of Analysis and Epidemiology, bOffice of Research Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD. cThe Herman & Walter Samuelson Children’s Hospital at Sinai, Baltimore, MD

    4 shared publications
  • Paul D. Sutton

    National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, USA

    4 shared publications

Latest Publications

  • Persistent Fungal Mortality in the United States Following the COVID-19 Pandemic Peak, 2022-2025

    by Meagan K. Andrews, Johnathan A. Edwards, Farida B. Ahmad, Jodi A. Cisewski, Lauren M. Rossen, Mitsuru Toda, Jeremy A.W. Gold

    Objectives: Fungal infection–associated deaths increased in the United States during the COVID-19 pandemic, but mortality patterns after the pandemic peak are not well-characterized. We analyzed national mortality data to assess whether fungal mortality remained elevated during 2022-2025 and to describe demographic, geographic, pathogen-specific, and underlying cause-of-death patterns after the COVID-19 pandemic peak. Methods: We analyzed National Vital Statistics System multiple-cause-of-death data for 2022-2025. We defined fungal deaths as deaths with a fungal pathogen listed as an underlying or contributing cause of death and summarized deaths by year, month, pathogen, COVID-19 association, underlying cause of death, demographic characteristics, and US Census division. We used 2018-2019 (prepandemic) and 2021 (peak) as reference periods for selected comparisons. Results: During 2022-2025, a total of 30 225 fungal deaths occurred (annual average = 7556). The annual age-adjusted mortality rate per 100 000 population increased from 1.2 in 2018-2019 to 1.5 in 2020 and 1.9 in 2021, and remained between 1.8 and 1.9 during 2022-2025. COVID-19–associated fungal deaths declined after early 2022, but overall fungal mortality remained stable. During 2022-2025, the most common underlying causes of death among fungal deaths were malignant neoplasms, HIV disease, and diseases of the heart; the most commonly specified pathogens were Candida and Aspergillus . Mortality rates varied by age, sex, race and ethnicity, and region. Conclusions: Fungal mortality remained elevated after the COVID-19 pandemic peak despite declines in COVID-19–associated fungal deaths. Continued efforts to monitor fungal disease–related mortality are important to inform efforts to enhance diagnostic capacity and surveillance to better characterize and ultimately reduce the impact of fungal diseases.

  • An ensemble modeling approach for estimating expected patterns in mortality in the United States

    by Lauren M. Rossen, Jodi A. Cisewski, Farida B. Ahmad, Robert N. Anderson

    Objectives: Excess mortality statistics are critical for quantifying the impact of various public health disasters and epidemics, particularly when deaths directly attributable to a given event may be underestimated. Prior research has found that excess mortality estimates can vary depending on the model used and various analytic decisions. Ensemble modeling approaches can mitigate these limitations by incorporating information from multiple models and better accounting for the uncertainty around analytic choices. The objective of this analysis was to evaluate the performance of an ensemble modeling approach to estimating excess mortality relative to methods that rely on single models. Methods: This study assesses an ensemble modeling approach to estimate excess mortality in the United States, based on weekly mortality data from the National Vital Statistics System from 2008 through 2024. We evaluated 76 candidate models with various long-term and seasonal trend specifications along with ensemble models. Results: Results indicate that an ensemble modeling approach offers more consistent and robust performance, with improved accuracy and coverage compared to individual models. Conclusions: This analysis highlights the utility of ensemble modeling in providing robust estimates of expected mortality, a critical resource for public health preparedness and response in the face of disasters or epidemics.

  • A review of recent nowcasting methods compensating for vital statistics reporting lags

    by Matthew Williams, Taylor Lewis, Sahar Zangeneh, Lauren M Rossen

    Producing timely, accurate, and granular estimates of public health outcomes is essential for effective public health surveillance and mitigation efforts. However, the production of these estimates is potentially delayed by reporting lags, which many times occur naturally in a data collection cycle. In this article, we review published nowcasting methods (i.e., predicting current events while accounting for reporting lags) with a focus on methods relevant for nowcasting vital statistics. Our aim is to classify the underlying modeling strategies and contexts, identify certain advantages and limitations, and present ideas for further research and development using promising statistical modeling techniques that, to the best of our knowledge, have not yet been utilized in any vital statistics nowcasting approaches.


  • Trends in maternal mortality rates by state, United States, 2018 to 2023

    by Lauren M. Rossen, Donna L. Hoyert, Isabelle Horon, Amy M. Branum


  • Trends and disparities in deaths among young persons in the US during the COVID-19 pandemic

    by Lauren M. Rossen, Adriana Resendez, Amanda Behdin, Michael St. Louis


  • US Trends in Maternal Mortality by Racial and Ethnic Group

    by Lauren M. Rossen, Donna Hoyert, Amy M. Branum

    To the Editor A recent article described increases in MMRs from 1999 to 2019, racial and ethnic disparities, and differences by US state. The use of bayesian mo


  • Open Access

    Excess all-cause mortality in the USA and Europe during the COVID-19 pandemic, 2020 and 2021

    by Lauren M. Rossen, Sarah K. Nørgaard, Paul D. Sutton, Tyra G. Krause, Farida B. Ahmad, Lasse S. Vestergaard, Kåre Mølbak, Robert N. Anderson, Jens Nielsen

    Both the USA and Europe experienced substantial excess mortality in 2020 and 2021 related to the COVID-19 pandemic. Methods used to estimate excess mortality vary, making comparisons difficult. This retrospective observational study included data on deaths from all causes occurring in the USA and 25 European countries or subnational areas participating in the network for European monitoring of excess mortality for public health action (EuroMOMO). We applied the EuroMOMO algorithm to estimate excess all-cause mortality in the USA and Europe during the first two years of the COVID-19 pandemic, 2020–2021, and compared excess mortality by age group and time periods reflecting three primary waves. During 2020–2021, the USA experienced 154.5 (95% Uncertainty Interval [UI]: 154.2–154.9) cumulative age-standardized excess all-cause deaths per 100,000 person years, compared with 110.4 (95% UI: 109.9–111.0) for the European countries. Excess all-cause mortality in the USA was higher than in Europe for nearly all age groups, with an additional 44.1 excess deaths per 100,000 person years overall from 2020–2021. If the USA had experienced an excess mortality rate similar to Europe, there would have been approximately 391 thousand (36%) fewer excess deaths in the USA.


  • Open Access

    Rural-Urban Differences in Maternal Mortality Trends in the United States, 1999–2017: Accounting for the Impact of the Pregnancy Status Checkbox

    by Lauren M Rossen, Katherine A Ahrens, Lindsay S Womack, Sayeedha F G Uddin, Amy M Branum

    It has been difficult to measure rural-urban differences in maternal mortality ratios (MMRs) in the United States in recent years because of the incremental adoption of a pregnancy status checkbox on the standard US death certificate. Using 1999–2017 mortality and birth data, we examined the impact of the pregnancy checkbox on MMRs according to urbanicity of residence (large urban area, medium/small urban area, or rural area), using log-binomial regression models to predict trends that would have been observed if all states had adopted the checkbox as of 1999. Implementation of the checkbox resulted in an average estimated increase of 7.5 maternal deaths per 100,000 live births (95% confidence interval (CI): 6.3, 8.8) in large urban areas (a 76% increase), 11.6 (95% CI: 9.6, 13.6) in medium/small urban areas (a 113% increase), and 16.6 (95% CI: 12.9, 20.3) in rural areas (a 107% increase), compared with MMRs prior to the checkbox. Assuming that all states had the checkbox as of 1999, demographic-factor–adjusted predicted MMRs increased in rural areas, declined in large urban areas, and did not change in medium/small urban areas. However, trends and urban-rural differences were substantially attenuated when analyses were limited to direct/specific causes of maternal death, which are probably subject to less misclassification. Accurate ascertainment of maternal deaths, particularly in rural areas, is important for reducing disparities in maternal mortality.


  • Top Cited Papers

    Disparities in Excess Mortality Associated with COVID-19 — United States, 2020

    by Lauren M. Rossen, Farida B. Ahmad, Robert N. Anderson, Amy M. Branum, Chengan Du, Harlan M. Krumholz, Shu-Xia Li, Zhenqiu Lin, Andrew Marshall, Paul D. Sutton, et al.

    This report describes excess mortality rates associated with COVID-19 among older people and certain racial/ethnic minority groups.